Early Warning Press Release Regarding CardioComm Solutions, Inc.

Rhea-AI Summary

Daniel Grima has acquired a total of 29,526,146 common shares of CardioComm Solutions (EKGGF) through debt settlement agreements.

Grima personally received 27,442,571 shares at $0.01 per share for settling $274,425.71 owed by the company. Additionally, his holding company, Xemxija Holdings, acquired 2,083,575 shares at $0.01 per share for settling $20,835.75 of debt.

Before the transaction, Grima held 6,910,555 shares (4.57% of the company). Post-transaction, he holds 36,436,702 shares, representing 18.87% of the total.

Grima's acquisition is for investment purposes, and he may adjust his holdings based on circumstances. The detailed disclosure can be reviewed on SEDAR+.

Positive

• Daniel Grima's acquisition significantly increases his stake in CardioComm Solutions to 18.87%, reflecting strong insider confidence in the company.

Negative

• The debt settlement through share issuance may lead to shareholder dilution, affecting existing shareholders' value.

Oakville, Ontario--(Newsfile Corp. - July 11, 2024) - Mr. Daniel Grima announces that he has acquired an aggregate of 29,526,146 common shares of CardioComm Solutions, Inc. ("EKG" or the "Company") pursuant to debt settlement transactions between the Company and Mr. Grima personally, as well as between the Company and Xemxija Holdings Inc. ("Xemxija"), Mr. Grima's holding company. Under a debt settlement agreement dated as of May 31, 2024 between the Company and Mr. Grima, Mr. Grima acquired 27,442,571 shares at a price of $0.01 per share as consideration for settling $274,425.71 of debt owed by the Company to Mr. Grima. In addition, under a debt settlement agreement dated as of May 31, 2024 between the Company and Xemxija, Xemxija acquired 2,083,575 shares at a price of $0.01 per share as consideration for settling $20,835.75 of debt owed by the Company to Xemxija.

Prior to the transactions, Mr. Grima held directly or indirectly (through Xemxija) an aggregate of 6,910,555 shares, representing approximately 4.57% of the issued and outstanding shares. Following the transactions, Mr. Grima holds an aggregate of 36,436,702 shares, representing approximately 18.87% of the issued and outstanding shares.

The shares were acquired by Mr. Grima for investment purposes. Depending upon the circumstances, Mr. Grima may, from time to time, acquire additional securities or related financial instruments of EKG or dispose of all or a portion of the securities or related financial instruments of EKG previously acquired. Other than the foregoing, Mr. Grima does not have plans or any future intentions which relate to or would result in any of the other foregoing matters.

"Daniel Grima "

Daniel Grima

The Form 62-103F1 - Required Disclosure under the Early Warning Requirements associated with this news release can be obtained from the Company's profile on SEDAR+ at www.sedarplus.ca. To obtain a copy of the report, please contact Mr. Grima of Oakville, Ontario, at +1(416) 977-9425 or dgrima@cardiocommsolutions.com.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/216263

FAQ

What is the recent share acquisition by Daniel Grima in CardioComm Solutions (EKGGF)?

Daniel Grima acquired 29,526,146 common shares of CardioComm Solutions (EKGGF) through debt settlement transactions.

How many shares did Daniel Grima receive in the debt settlement with CardioComm Solutions?

Daniel Grima received 27,442,571 shares personally and 2,083,575 shares through his holding company, Xemxija Holdings.

What percentage of CardioComm Solutions does Daniel Grima hold after the acquisition?

Following the acquisition, Daniel Grima holds 18.87% of the issued and outstanding shares of CardioComm Solutions.

At what price per share were the debt settlements made between Daniel Grima and CardioComm Solutions?

The debt settlements were made at a price of $0.01 per share.

Where can I find the Early Warning Disclosure related to Daniel Grima's acquisition?

The Early Warning Disclosure can be found on SEDAR+ under CardioComm Solutions' profile.